Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Clinical Investigation

• Publication date

  2011-05-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI43792PMID 21490396PMCID PMC3083784
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stat3: linking inflammation to epithelial cancer - more than a "gut" feeling?

  2010cited by this paper
• The role of COX-2 in intestinal inflammation and colorectal cancer

  2010cited by this paper
• Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin–Yang interplay between inflammation and cancer

  2010cited by this paper
• Heparanase Alters Arterial Structure, Mechanics, and Repair Following Endovascular Stenting in Mice

  2009cited by this paper
• gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis.

  2009cited by this paper
• Innate immune signaling by Toll‐like receptor‐4 (TLR4) shapes the inflammatory microenvironment in colitis‐associated tumors

  2009cited by this paper
• Resistin-Like Molecule α Decreases Glucose Tolerance during Intestinal Inflammation1

  2009cited by this paper
• IKK/NF‐κB and STAT3 pathways: central signalling hubs in inflammation‐mediated tumour promotion and metastasis

  2009cited by this paper
• IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer.

  2009cited by this paper
• STATs in cancer inflammation and immunity: a leading role for STAT3

  2009cited by this paper
• Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis.

  2008cited by this paper
• TNFR1 Promotes Tumor Necrosis Factor-mediated Mouse Colon Epithelial Cell Survival through RAF Activation of NF-κB*

  2008cited by this paper
• Heparanase: One Molecule with Multiple Functions in Cancer Progression

  2008cited by this paper
• Cathepsin L Is Responsible for Processing and Activation of Proheparanase through Multiple Cleavages of a Linker Segment*

  2008cited by this paper
• Role of cytokines in inflammatory bowel disease.

  2008cited by this paper
• Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors.

  2007cited by this paper
• Heparanase upregulation by colonic epithelium in inflammatory bowel disease

  2007cited by this paper
• Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study.

  2007cited by this paper
• Heparanase Enhances Syndecan-1 Shedding

  2007cited by this paper
• Spatial and temporal heparanase expression in colon mucosa throughout the adenoma-carcinoma sequence

  2006cited by this paper
• Angiogenesis blockade as a new therapeutic approach to experimental colitis

  2006cited by this paper
• Increased expression of heparanase in overt diabetic nephropathy.

  2006cited by this paper
• Heparanase is expressed in osteoblastic cells and stimulates bone formation and bone mass

  2006cited by this paper
• Colon cancer--understanding how NSAIDs work.

  2006cited by this paper
• Cathepsins B, L and D in inflammatory bowel disease macrophages and potential therapeutic effects of cathepsin inhibition in vivo

  2006cited by this paper
• Early Growth Response Gene 1 (EGR1) Regulates Heparanase Gene Transcription in Tumor Cells*

  2005cited by this paper
• Heparanase accelerates wound angiogenesis and wound healing in mouse and rat models

  2005cited by this paper
• NF-κB: linking inflammation and immunity to cancer development and progression

  2005cited by this paper
• NF-kappaB: linking inflammation and immunity to cancer development and progression.

  2005cited by this paper
• In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis.

  2005cited by this paper
• Heparanase expression correlates with malignant potential in human colon cancer

  2005cited by this paper
• Conditional signaling by Toll‐like receptor 4

  2005cited by this paper
• IL-6 Signaling Promotes Tumor Growth in Colorectal Cancer

  2005cited by this paper
• The role of heparanase in gastrointestinal cancer (Review).

  2005cited by this paper
• Microsomal Prostaglandin E Synthase-1 Is Overexpressed in Inflammatory Bowel Disease

  2004cited by this paper
• IKK Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer

  2004cited by this paper
• Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.

  2004cited by this paper
• Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior

  2004cited by this paper
• Heparanase expression in human colorectal cancer and its relationship to tumor angiogenesis, hematogenous metastasis, and prognosis

  2004cited by this paper
• Inflammatory cytokines and fatty acids regulate endothelial cell heparanase expression.

  2004cited by this paper
• Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.

  2004cited by this paper
• Tumour-educated macrophages promote tumour progression and metastasis

  2004cited by this paper
• High heparanase activity in multiple myeloma is associated with elevated microvessel density.

  2003cited by this paper
• Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease

  2003cited by this paper
• The immunological and genetic basis of inflammatory bowel disease

  2003cited by this paper
• Invariant Chain Controls the Activity of Extracellular Cathepsin L

  2002cited by this paper
• Dysplasia and carcinoma development in a repeated dextran sulfate sodium‐induced colitis model

  2002cited by this paper
• The Phosphatidylinositol 3-Kinase-Akt Pathway Limits Lipopolysaccharide Activation of Signaling Pathways and Expression of Inflammatory Mediators in Human Monocytic Cells*

  2002cited by this paper
• Collagen-binding integrin α1β1 regulates intestinal inflammation in experimental colitis

  2002cited by this paper
• Inflammation and cancer

  2002cited by this paper
• Collagen-binding integrin alpha1beta1 regulates intestinal inflammation in experimental colitis.

  2002cited by this paper
• Constitutively Activated Akt-1 Is Vital for the Survival of Human Monocyte-Differentiated Macrophages

  2001cited by this paper
• Heparan sulfate proteoglycans: intricate molecules with intriguing functions.

  2001cited by this paper
• Heparanase: a key enzyme involved in cell invasion.

  2001cited by this paper
• Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway.

  2000cited by this paper
• The key role of macrophages in the immunopathogenesis of inflammatory bowel disease.

  2000cited by this paper
• Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis.

  2000cited by this paper
• The role of cyclooxygenase 2 in ulcerative colitis-associated neoplasia.

  2000cited by this paper
• The key role of macrophages in the immunopathogenesis of inflammatory bowel disease

  2000cited by this paper
• Toll-like receptor 2–mediated NF-κB activation requires a Rac1-dependent pathway

  2000cited by this paper
• Activators and target genes of Rel/NF-kappaB transcription factors.

  1999cited by this paper
• Activators and target genes of Rel/NF-κB transcription factors

  1999cited by this paper
• Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis

  1999cited by this paper
• Expression of E-Selectin, Sialyl Lewis X, and Macrophage Inflammatory Protein-1α by Colonic Epithelial Cells in Ulcerative Colitis

  1998cited by this paper
• Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2

  1998cited by this paper
• Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

  1998cited by this paper
• Modulation of fibroblast growth factor-2 receptor binding, dimerization, signaling, and angiogenic activity by a synthetic heparin-mimicking polyanionic compound.

  1997cited by this paper
• Promotion of colorectal neoplasia in experimental murine ulcerative colitis.

  1996cited by this paper
• Experimental models of inflammatory bowel disease.

  1995cited by this paper
• Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation.

  1992cited by this paper
• Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism?

  1991cited by this paper
• A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice.

  1990cited by this paper
• A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice

  1990cited by this paper
• The mouse macrophage-specific glycoprotein defined by monoclonal antibody F4/80: characterization, biosynthesis and demonstration of a rat analogue.

  1987cited by this paper
• Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: relationship to tumor cell metastasis.

  1983cited by this paper
• GASTROENTEROLOGY 2006;130:2060–2073 Angiogenesis as a Novel Component of Inflammatory Bowel Disease Pathogenesis

  year unknowncited by this paper
• The FASEB Journal express article 10.1096/fj.00-0895fje. Published online May 29, 2001.

  year unknowncited by this paper

• The emerging role of heparanase in cardiovascular diseases: Pathophysiology, clinical outcomes, and therapeutic perspectives.

  2026cites this paper
• An anti-miR-301a and zinc coordination driven nanozyme loaded in nanoparticle for oral therapy of inflammatory bowel disease based on colitis microenvironment regulation

  2025cites this paper
• Role of syndecan-4 in angiogenesis and vasculogenic mimicry in triple negative breast cancer cells.

  2025cites this paper
• Proteases in intestinal health and disease

  2025cites this paper
• Heparan Sulfate Proteoglycans (HSPGs) and Their Degradation in Health and Disease

  2025cites this paper
• Identification of potential diagnostic markers and molecular mechanisms of asthma and ulcerative colitis based on bioinformatics and machine learning

  2025cites this paper
• The Pathophysiological Functions of Heparanases: From Evolution, Structural and Tissue‐Specific Perspectives

  2025cites this paper
• Natural products with anti-tumorigenesis potential targeting macrophage.

  2024cites this paper
• How the Western Diet Thwarts the Epigenetic Efforts of Gut Microbes in Ulcerative Colitis and Its Association with Colorectal Cancer

  2024cites this paper
• The pressing need for study on the effects of Mpox on the progression of vascular inflammation: A well‐timed call

  2024cites this paper
• Heparanase 2 Modulation Inhibits HSV-2 Replication by Regulating Heparan Sulfate

  2024cites this paper
• The Uptake of Heparanase into Mast Cells Is Regulated by Its Enzymatic Activity to Degrade Heparan Sulfate

  2024cites this paper
• Heparanase is the possible link between monkeypox and Covid-19: robust candidature in the mystic and present perspective

  2023cites this paper
• Discrepancy between recipient and donor rs4364254 heparanase single nucleotide polymorphism impacts graft‐versus‐host disease after allogeneic stem cell transplant

  2023cites this paper
• Role of heparanase in pulmonary hypertension

  2023cites this paper
• Sulodexide improves vascular permeability via glycocalyx remodelling in endothelial cells during sepsis

  2023cites this paper
• Constipation in DM are associated with both poor glycemic control and diabetic complications: Current status and future directions.

  2023cites this paper
• Heparanase—A single protein with multiple enzymatic and nonenzymatic functions

  2023cites this paper
• Role of heparanase in ARDS through autophagy and exosome pathway (review)

  2023cites this paper
• Heparanase Modulates Chromatin Accessibility

  2023cites this paper
• Heparanase contributes to pancreatic carcinoma progression through insulin-dependent glucose uptake

  2023cites this paper
• Endothelial Glycocalyx of Peritubular Capillaries in Experimental Diabetic Nephropathy: A Target of ACE Inhibitor-Induced Kidney Microvascular Protection

  2023cites this paper
• Heparanase inhibition leads to improvement in patients with acute gastrointestinal injuries induced by sepsis

  2023cites this paper
• Inflammatory Bowel Disease-Associated Gut Commensals Degrade Components of the Extracellular Matrix

  2022cites this paper
• Sulfated Hyaluronan Binds to Heparanase and Blocks Its Enzymatic and Cellular Actions in Carcinoma Cells

  2022cites this paper
• Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19

  2022cites this paper
• Blood transcriptomic biomarkers of alcohol consumption and cardiovascular disease risk factors: the Framingham Heart Study

  2022cites this paper
• Targeting the “sweet spot” in septic shock – A perspective on the endothelial glycocalyx

  2022cites this paper
• Heparanase: A Novel Therapeutic Target for the Treatment of Atherosclerosis

  2022cites this paper
• Macrophages Upregulate Estrogen Receptor Expression in the Model of Obesity-Associated Breast Carcinoma

  2022cites this paper
• The Heparanase Regulatory Network in Health and Disease

  2021influential citation
• Structural Biology of the Tumor Microenvironment.

  2021cites this paper
• Role of heparinase in the gastrointestinal dysfunction of sepsis (Review)

  2021influential citation
• Targeting the “sweet spot” in septic shock – A perspective on the endothelial glycocalyx regulating proteins Heparanase-1 and -2

  2021cites this paper
• Upregulation of ERK-EGR1-heparanase axis by HDAC inhibitors provides targets for rational therapeutic intervention in synovial sarcoma

  2021cites this paper
• Heparanase is a novel biomarker for immune infiltration and prognosis in breast cancer

  2021cites this paper
• New Heparanase-Inhibiting Triazolo-Thiadiazoles Attenuate Primary Tumor Growth and Metastasis

  2021cites this paper
• Helicobacter pylori-Induced Heparanase Promotes H. pylori Colonization and Gastritis

  2021influential citation
• Parabacteroides produces acetate to alleviate heparanase-exacerbated acute pancreatitis through reducing neutrophil infiltration

  2021cites this paper
• Biology of the Heparanase–Heparan Sulfate Axis and Its Role in Disease Pathogenesis

  2021influential citation
• A guide to the composition and functions of the extracellular matrix

  2021cites this paper
• miR-558 Reduces the Damage of HBE Cells Exposed to Cigarette Smoke Extract by Targeting TNFRSF1A and Inactivating TAK1/MAPK/NF-κB Pathway

  2021cites this paper
• Extracellular matrix changes in colorectal carcinoma and correlation with lymph node metastasis

  2021cites this paper
• Glycosylation changes in inflammatory diseases.

  2020cites this paper
• Involvement of Syndecan-1 and Heparanase in Cancer and Inflammation.

  2020cites this paper
• Heparanase-The Message Comes in Different Flavors.

  2020cites this paper
• Heparanase in Kidney Disease.

  2020cites this paper
• MCTR1 alleviates lipopolysaccharide‐induced acute lung injury by protecting lung endothelial glycocalyx

  2020cites this paper
• Role of Heparanase in Macrophage Activation.

  2020cites this paper
• Forty Years of Basic and Translational Heparanase Research

  2020cites this paper
• Revisiting Cancer Stem Cells as the Origin of Cancer-Associated Cells in the Tumor Microenvironment: A Hypothetical View from the Potential of iPSCs

  2020cites this paper
• University of Birmingham MCTR1 alleviates lipopolysaccharide-induced acute lung injury by protecting lung endothelial glycocalyx

  2020cites this paper
• Role of Heparanase in tumor progression: molecular aspects and therapeutic options.

  2020cites this paper
• Bidens pilosa (Black Jack) Standardized Extract Ameliorates Acute TNBS-induced Intestinal Inflammation in Rats

  2020cites this paper
• Effect of heparanase inhibitor on tissue factor overexpression in platelets and endothelial cells induced by anti‐β2‐GPI antibodies

  2020cites this paper
• Heparanase and the hallmarks of cancer

  2020cites this paper
• Dichotomic role of heparanase in a murine model of metabolic syndrome

  2020cites this paper
• Heparanase-enhanced Shedding of Syndecan-1 and Its Role in Driving Disease Pathogenesis and Progression

  2020cites this paper
• Significance of host heparanase in promoting tumor growth and metastasis.

  2020cites this paper
• In Search of Newer Targets for IBD: A Systems and a Network Medicine Approach

  2020cites this paper
• Sirtuin 1 and endothelial glycocalyx

  2020cites this paper
• Heparanase, cell signaling, and viral infections

  2020cites this paper
• Upregulation of Fecal Epithelial Heparanase mRNA Is Associated with Increased Ulcerative Colitis Activity and Cancerization Risk

  2020cites this paper
• Syndecan-1-Dependent Regulation of Heparanase Affects Invasiveness, Stem Cell Properties, and Therapeutic Resistance of Caco2 Colon Cancer Cells

  2020cites this paper
• Induction of heparanase via IL-10 correlates with a high infiltration of CD163+ M2-type tumor-associated macrophages in inflammatory breast carcinomas

  2020cites this paper
• Mechanism of HPSE Gene SNPs Function: From Normal Processes to Inflammation, Cancerogenesis and Tumor Progression.

  2020cites this paper
• Heparanase: Historical Aspects and Future Perspectives.

  2020cites this paper
• Heparanase in Acute Kidney Injury.

  2020cites this paper
• Heparanase and Type 1 Diabetes.

  2020cites this paper
• Impact of Heparanse on Organ Fibrosis.

  2020cites this paper
• Heparanase in Acute Pancreatitis.

  2020cites this paper
• Peripheral neuropathy following bortezomib therapy in multiple myeloma patients: association with cumulative dose, heparanase, and TNF-α

  2019cites this paper
• Heparanase-2 protects from endothelial injury by inhibiting TLR4 signaling

  2019cites this paper
• Chondroitin sulfate E blocks enzymatic action of heparanase and heparanase-induced cellular responses.

  2019cites this paper
• Heparanase-2 protects from LPS-mediated endothelial injury by inhibiting TLR4 signalling

  2019cites this paper
• Heparanase accelerates obesity-associated breast cancer progression.

  2019cites this paper
• Regulation of Heparanase in Diabetes-Associated Pancreatic Carcinoma

  2019cites this paper
• Leukocyte Heparanase: A Double-Edged Sword in Tumor Progression

  2019cites this paper
• Systemic LPS-induced Aβ-solubilization and clearance in AβPP-transgenic mice is diminished by heparanase overexpression

  2019cites this paper
• Transcriptomic analysis reveals cell apoptotic signature modified by heparanase in melanoma cells

  2019cites this paper
• Targeting Heparanase in Cancer: Inhibition by Synthetic, Chemically Modified, and Natural Compounds

  2019cites this paper
• Laminin-511: a key regulator of breast cancer metastasis

  2018cites this paper
• Loss of intra-islet heparan sulfate is a highly sensitive marker of type 1 diabetes progression in humans

  2018cites this paper
• The Role of Heparan Sulfate in Inflammation, and the Development of Biomimetics as Anti-Inflammatory Strategies

  2018cites this paper
• Involvement of Heparanase in the Pathogenesis of Mesothelioma: Basic Aspects and Clinical Applications

  2018cites this paper
• Heparan Sulfate Proteoglycans as Relays of Neuroinflammation

  2018influential citation
• Preventive effect on endothelial surface layer damage of Fusu agent in LPS-induced acute lung injury in rats

  2018cites this paper
• Heparanase: A Multitasking Protein Involved in Extarcellular Matrix (ECM) Remodeling and Cellular Signaling

  2018cites this paper
• Incorporation, intracellular trafficking and processing of extracellular heparanase by mast cells: Involvement of syndecan-4-dependent pathway.

  2018cites this paper
• Heparan Sulfate Mimetics in Cancer Therapy: The Challenge to Define Structural Determinants and the Relevance of Targets for Optimal Activity

  2018cites this paper
• 1 Heparanase : A Multitasking Protein Involved In 2 Extarcellular Matrix ( ECM ) Remodeling And 3 Intracellular Events 4

  2018cites this paper
• Heparan sulfate dependent cell signaling and associated pathophysiology : Implications in tumorigenesis and embryogenesis

  2018cites this paper
• Heparanase: A Multitasking Protein Involved in Extracellular Matrix (ECM) Remodeling and Intracellular Events

  2018cites this paper
• MET/HGF Co-Targeting in Pancreatic Cancer: A Tool to Provide Insight into the Tumor/Stroma Crosstalk

  2018cites this paper
• Heparanase inhibitors restrain mesothelioma

  2018cites this paper
• Understanding Heparan Sulfate Biosynthesis and Functional Implications of Heparanase.

  2018cites this paper
• The Glomerular Endothelium in Diabetic Nephropathy: Role of Heparanase

  2018cites this paper
• Gemcitabine-induced heparanase promotes aggressiveness of pancreatic cancer cells via activating EGFR signaling

  2017cites this paper
• The Role of Heparanase in the Pathogenesis of Acute Pancreatitis: A Potential Therapeutic Target

  2017cites this paper
• The Role of the Nucleosome Remodeling Factor NURF in Inhibiting T and Natural Killer Cell Mediated Antitumor Immunity by Suppressing Tumor Antigenicity and Natural Cytotoxicity Receptor Co-ligands

  2017cites this paper